Your browser doesn't support javascript.
loading
Real-world performance of SARS-Cov-2 serology tests in the United States, 2020.
Rodriguez-Watson, Carla V; Louder, Anthony M; Kabelac, Carly; Frederick, Christopher M; Sheils, Natalie E; Eldridge, Elizabeth H; Lin, Nancy D; Pollock, Benjamin D; Gatz, Jennifer L; Grannis, Shaun J; Vashisht, Rohit; Ghauri, Kanwal; Knepper, Camille; Leonard, Sandy; Embi, Peter J; Jenkinson, Garrett; Klesh, Reyna; Garner, Omai B; Patel, Ayan; Dahm, Lisa; Barin, Aiden; Cooper, Dan M; Andriola, Tom; Byington, Carrie L; Crews, Bridgit O; Butte, Atul J; Allen, Jeff.
Afiliación
  • Rodriguez-Watson CV; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.
  • Louder AM; Aetion, New York, New York, United States of America.
  • Kabelac C; Aetion, New York, New York, United States of America.
  • Frederick CM; Regenstrief Institute, Indianapolis, Indiana, United States of America.
  • Sheils NE; Optum Labs, Minnetonka, Minnesota, United States of America.
  • Eldridge EH; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Lin ND; Health Catalyst, Salt Lake City, Utah, United States of America.
  • Pollock BD; Mayo Clinic, Rochester, Minnesota, United States of America.
  • Gatz JL; Regenstrief Institute, Indianapolis, Indiana, United States of America.
  • Grannis SJ; Regenstrief Institute, Indianapolis, Indiana, United States of America.
  • Vashisht R; Department of Family Medicine, Indiana University School of Medicine, Indianapolis, Indiana, United States of America.
  • Ghauri K; Bakar Computational Health Sciences Institute, University of California, San Francisco, San Francisco, California, United States of America.
  • Knepper C; Reagan-Udall Foundation for the FDA, Washington, District of Columbia, United States of America.
  • Leonard S; Mayo Clinic, Rochester, Minnesota, United States of America.
  • Embi PJ; HealthVerity, Philadelphia, Pennsylvania, United States of America.
  • Jenkinson G; Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
  • Klesh R; Mayo Clinic, Rochester, Minnesota, United States of America.
  • Garner OB; HealthVerity, Philadelphia, Pennsylvania, United States of America.
  • Patel A; Department of Pathology and Laboratory Medicine, UCLA Medical Center, Los Angeles, California, United States of America.
  • Dahm L; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
  • Barin A; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
  • Cooper DM; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
  • Andriola T; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
  • Byington CL; Pediatric Exercise and Genomics Research Center, University of California Irvine School of Medicine, Irvine, California, United States of America.
  • Crews BO; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
  • Butte AJ; Office of Data and Information Technology, University of California, Irvine, Irvine, California, United States of America.
  • Allen J; Center for Data-Driven Insights and Innovation, University of California Health, Oakland, California, United States of America.
PLoS One ; 18(2): e0279956, 2023.
Article en En | MEDLINE | ID: mdl-36735683

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos